BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9769687)

  • 1. [Current data on familial occurrence of malignant hematologic diseases in the County of Szabolcs-Szatmár-Bereg in Hungary].
    Jakó J; Szerafin L; Nagy P; Babicz T
    Orv Hetil; 1998 Sep; 139(37):2187-9. PubMed ID: 9769687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cases of familial leukemia-lymphoma in Szabolcs-Szatmár-Bereg County].
    Jakó J; Szerafin L; Póth I; Nagy P; Smanykó D; Babicz T
    Orv Hetil; 1992 Jan; 133(3):147-8, 153. PubMed ID: 1734343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticipation in familial malignant hematologic diseases (epidemiologic observations)].
    Jakó J; Szerafin L; Nagy P; Babicz T
    Orv Hetil; 2002 Aug; 143(32):1887-91. PubMed ID: 12221994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence of haematological malignancies in adults in Szabolcs-Szatmár-Bereg county, Hungary, between 1983 and 2012. Analysis of data from a thirty-year period].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2013 Nov; 154(47):1858-64. PubMed ID: 24240522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of the data from the Szabolcs-Szatmár County 1983-1987 leukemia/lymphoma registry].
    Jakó J; Nagy P
    Orv Hetil; 1990 Feb; 131(8):411-4. PubMed ID: 2314880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiologic features of Philadelphia-negative chronic myeloproliferative disorders in Szabolcs-Szatmár-Bereg county, Hungary. Analysis of data of a 33-year period].
    Jakó J; Szerafin L
    Orv Hetil; 2017 Apr; 158(15):572-578. PubMed ID: 28393599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extranodal lymphomas in adults in Szabolcs-Szatmár-Bereg county, Hungary. Analysis of 30 years' epidemiologic data].
    Jakó J; Szerafin L
    Orv Hetil; 2015 Jan; 156(3):98-104. PubMed ID: 25577681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiologic features of myeloma in Szabolcs-Szatmár-Bereg county, Hungary. Analysis of data of a 33-year period].
    Jakó J; Szerafin L
    Orv Hetil; 2016 Aug; 157(34):1357-60. PubMed ID: 27546802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anteposition in malignant hematologic diseases of siblings in Szabolcs-Szatmár-Bereg county, Hungary. Analysis of data of a 34-year period].
    Jakó J; Szerafin L
    Orv Hetil; 2017 Aug; 158(33):1283-1287. PubMed ID: 28806110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence of haematological malignancies in adults in Szabolcs-Szatmár-Bereg county, Hungary. Analysis of data of a 36-year period].
    Jakó J; Takács P; Szerafin L
    Orv Hetil; 2020 Aug; 161(34):1400-1413. PubMed ID: 32804670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Familial occurrence of malignant hematologic diseases].
    Chrz M; Benesová E; Ceslar P; Trnĕný M
    Cas Lek Cesk; 1992 Jun; 131(14):437-42. PubMed ID: 1369814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Hodgkin's lymphoma and family history of hematologic malignancy.
    Mensah FK; Willett EV; Ansell P; Adamson PJ; Roman E
    Am J Epidemiol; 2007 Jan; 165(2):126-33. PubMed ID: 17071845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incidence of myocardial infarction in Hungary. Population study in five districts of Budapest and Szabolcs-Szatmár-Bereg county].
    Jánosi A; Ofner P; Branyickiné Géczy G; Polgár P
    Orv Hetil; 2013 Jul; 154(28):1106-10. PubMed ID: 23835356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
    Chatterjee N; Hartge P; Cerhan JR; Cozen W; Davis S; Ishibe N; Colt J; Goldin L; Severson RK
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1415-21. PubMed ID: 15342441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Second malignancies in patients treated for Hodgkin's disease].
    Keresztes K; Miltényi Z; András C; Illés A
    Magy Onkol; 2002; 46(3):247-51. PubMed ID: 12368920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An experience with sixty cases of haematological malignancies; a clinico haematological correlation.
    Idris M; Shah SH; Fareed J; Gul N
    J Ayub Med Coll Abbottabad; 2004; 16(4):51-4. PubMed ID: 15762065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment and preliminary evaluation of the General Practitioners' Morbidity Sentinel Stations Program in Hungary. Prevalence of hypertension, diabetes mellitus and liver cirrhosis].
    Széles G; Vokó Z; Jenei T; Kardos L; Bajtay A; Hamburger I; Kósa Z; Pénzes M; Tokár Z; Paul Z; Papp E; Menyhárt I; Parragi K; Horváth G; Ertner S; Esenszki B; Fodor M; Molnár I; Lun K; Adány R
    Orv Hetil; 2003 Aug; 144(31):1521-9. PubMed ID: 14502866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family history of hemolymphopoietic and other cancers and risk of non-Hodgkin's lymphoma.
    Negri E; Talamini R; Montella M; Dal Maso L; Crispo A; Spina M; La Vecchia C; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):245-50. PubMed ID: 16492911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France.
    Hausfater P; Cacoub P; Sterkers Y; Thibault V; Amoura Z; Nguyen L; Ghillani P; Leblond V; Piette JC
    Am J Hematol; 2001 Jul; 67(3):168-71. PubMed ID: 11391713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.